# Cyclobenzaprine Hydrochloride

NDC: 85509-1035
Generic name: Cyclobenzaprine Hydrochloride
Labeler / Manufacturer: PHOENIX RX LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20190301

FDA application: ANDA091281

## Active ingredients

- CYCLOBENZAPRINE HYDROCHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85509-1035"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85509-1035
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=48c33e51-db07-af68-e063-6294a90a897e